# Vetter Pharma

PFS & Auto-injectors — Dual-chamber syringe assembly.

Source: https://en.bioecon.ru/companies/vetter-pharma/
Updated: 2026-07-02

- Country: Germany

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | EUR 47 million in EU-approved state aid for the Saarlouis facility project (2026-06-02) | https://www.vetter-pharma.com/media/content/Downloads/Nachhaltigkeit/Nachhaltigkeitsbericht/Vetter_Sustainability_Report_2025_3.pdf |
| Capacity | 77.2 million device assembly and packaging units processed in 2025 (2025-12-31) | https://www.vetter-pharma.com/media/content/Downloads/Unternehmen/Vetter_Brochure_2026.pdf |
| Certification | ISO 14001, ISO, GMP (2026-09-02) | https://pharmasource.global/directory/vetter/ |
| Regulatory approval | FDA, EMA, PMDA, Tübingen Regional Council (2026-09-02) | https://www.vetter-pharma.com/media/content/Downloads/Nachhaltigkeit/Nachhaltigkeitsbericht/Vetter_Sustainability_Report_2025_3.pdf |
| Production site | Ravensburg and Langenargen, Germany; Rankweil, Austria; Des Plaines, USA (Chicago area) (2026-09-02) | https://ondrugdelivery.com/company-showcase-vetter-pharma/, https://www.vetter-pharma.com/media/content/Downloads/Presse/Vetter_Presskit_2026.pdf |
| Headcount | 7,300+ employees worldwide (2026-09-02) | https://www.vetter-pharma.com/media/content/Downloads/Unternehmen/Vetter_Brochure_2026.pdf |
| Revenue | EUR 1.26 billion in 2025 sales revenue (2025-12-31) | https://www.vetter-pharma.com/media/content/Downloads/Nachhaltigkeit/Nachhaltigkeitsbericht/Vetter_Sustainability_Report_2025_3.pdf, https://www.vetter-pharma.com/media/content/Downloads/Presse/Vetter_Presskit_2026.pdf |

Independent sources: ondrugdelivery.com, pharmasource.global

## Technologies

- [Fill-finish & aseptic biomanufacturing](https://en.bioecon.ru/technology/fill-finish-aseptic-biomanufacturing/)